Matthew Young - Enact Holdings Senior Sales
| ACT Etf | USD 34.62 0.23 0.67% |
| Address | 8325 Six Forks Road, Raleigh, NC, United States, 27615 |
| Phone | 919 846 4100 |
| Web | https://enactmi.com |
Matthew Young Latest Insider Activity
Tracking and analyzing the buying and selling activities of Matthew Young against Enact Holdings etf is an integral part of due diligence when investing in Enact Holdings. Matthew Young insider activity provides valuable insight into whether Enact Holdings is net buyers or sellers over its current business cycle. Note, Enact Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Enact Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Matthew Young over six months ago Acquisition by Matthew Young of 20000 shares of CytomX Therapeutics subject to Rule 16b-3 | ||
Matthew Young over a year ago Acquisition by Matthew Young of 25000 shares of CytomX Therapeutics subject to Rule 16b-3 | ||
Matthew Young over a year ago Payment of 1348 shares by Matthew Young of Jazz Pharmaceuticals subject to Rule 16b-3 |
Enact Holdings Management Efficiency
The company has Return on Asset of 0.093 % which means that on every $100 spent on assets, it made $0.093 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1438 %, implying that it generated $0.1438 on every 100 dollars invested. Enact Holdings' management efficiency ratios could be used to measure how well Enact Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Michael Hoffmann | James River Group | 59 | |
| Dianna Higgins | MGIC Investment Corp | N/A | |
| Russell Brewer | Assured Guaranty | 63 | |
| Norman Fitzgerald | NMI Holdings | 57 | |
| Annette Adams | MGIC Investment Corp | N/A | |
| Howard Beck | ICC Holdings | 65 | |
| Kelley Kage | Employers Holdings | N/A | |
| Michael Cobb | AMERISAFE | 48 | |
| Henry IV | AMERISAFE | 63 | |
| Rhonta Smith | Ambac Financial Group | 53 | |
| FRM CFA | Radian Group | N/A | |
| Jonathan Harris | MBIA Inc | 52 | |
| Christina Ozuna | Employers Holdings | N/A | |
| John Damian | Radian Group | N/A | |
| Ling Chow | Assured Guaranty | 50 | |
| Robert Tucker | Assured Guaranty | N/A | |
| Julia Suiter | ICC Holdings | 57 | |
| Emily Riley | Radian Group | N/A | |
| Robert CPA | Assured Guaranty | 58 | |
| Angela Pearson | AMERISAFE | 51 | |
| Steve Keleher | Radian Group | N/A | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.093 |
Enact Holdings Money Managers
| Matthew Young, Senior Sales | ||
| Daniel Kohl, Vice Relations | ||
| James McMullen, VP Controller | ||
| Brian Gould, EVP COO | ||
| Rohit Gupta, CEO President | ||
| Neenu Kainth, Senior Officer | ||
| Susan Sullivan, Senior Officer | ||
| Hardin Mitchell, CFO VP | ||
| Evan Stolove, General VP | ||
| Michael Derstine, Executive Officer |
Enact Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Enact Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.093 | ||||
| Profit Margin | 0.57 % | ||||
| Operating Margin | 0.78 % | ||||
| Current Valuation | 5.35 B | ||||
| Shares Outstanding | 153.59 M | ||||
| Shares Owned By Insiders | 81.45 % | ||||
| Shares Owned By Institutions | 19.38 % | ||||
| Number Of Shares Shorted | 1.44 M | ||||
| Price To Earning | 5.66 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Enact Etf
Enact Holdings financial ratios help investors to determine whether Enact Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enact with respect to the benefits of owning Enact Holdings security.